Chemours (CC) PT Lowered to $26 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.24 +2.97%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $26.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments
- Riskified Ltd. (RSKD) PT Raised to $5.50 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
